Camrelizumab (Camre) plus taxane-based chemotherapy (CT): Clinical outcomes and dynamic monitoring of CEA as a predictive biomarker of response in patients with recurrent or advanced esophageal squamous cell carcinoma (ESCC).

被引：0
|
作者：
Kong, Cheng
Xu, Jianhua
Jiang, Ming
Zhu, Xiangzhi
Ye, Jinjun
Yu, Shaorong
Zhu, Jun
机构：
[1] Jiangsu Canc Hosp, Nanjing, Peoples R China
[2] Nanjing Med Univ, Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16524
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
    Peng Yang
    Xiao Zhou
    Xuefeng Yang
    Yuefeng Wang
    Tao Sun
    Shiying Feng
    Xianyou Ma
    World Journal of Surgical Oncology, 19
  • [2] Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
    Yang, Peng
    Zhou, Xiao
    Yang, Xuefeng
    Wang, Yuefeng
    Sun, Tao
    Feng, Shiying
    Ma, Xianyou
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [3] Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study
    Liu, Jun
    Li, Jingpei
    Lin, Wanli
    Shao, Di
    Depypere, Lieven
    Zhang, Zhifeng
    Li, Zhuoyi
    Cui, Fei
    Du, Zesen
    Zeng, Yuan
    Jiang, Shunjun
    He, Ping
    Gu, Xia
    Chen, Huai
    Zhang, Hai
    Lin, Xiaowei
    Huang, Haoda
    Lv, Wenqiang
    Cai, Weiming
    Liang, Wenhua
    Liang, Hengrui
    Jiang, Wenxi
    Wang, Wei
    Xu, Ke
    Cai, Weipeng
    Wu, Kui
    Lerut, Toni
    Fu, Junhui
    He, Jianxing
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (01) : 128 - 137
  • [4] Three courses of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective phase II clinical trial
    Yang, G.
    Sun, X.
    Yang, H.
    Luo, G.
    Zheng, Y.
    Huang, M.
    Wang, Z.
    Cai, P.
    He, H.
    Xiang, J.
    Cai, M.
    Fu, J.
    Liu, Q.
    Yi, H.
    Zhong, J.
    Huang, Y.
    Guo, Q.
    Zhang, X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1122 - S1122
  • [5] Two cycles versus four cycles of neoadjuvant camrelizumab plus chemotherapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, multicenter and randomized study.
    Zhang, Qin
    Cao, Guochun
    Fan, Zhaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 350 - 350
  • [6] SHR-1701 plus chemotherapy as first-line treatment for unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC).
    Wang, Yi
    Liu, Hong
    Wang, Qingwei
    Qiao, Naian
    Wang, Jianbo
    Tan, Bingxu
    Cheng, Bo
    Chu, Yunxia
    Li, Huajun
    Cheng, Yufeng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 363 - 363
  • [7] Camrelizumab plus chemotherapy as neoadjuvant treatment for resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC): A single-center, randomized, phase II trial
    Lu, Zhihao
    Cao, Yanshuo
    Dai, Liang
    Dong, Fengxiao
    Shen, Lin
    CANCER RESEARCH, 2024, 84 (07)
  • [8] Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT in advanced or metastatic esophageal squamous cell carcinoma (ESCC): PD-L1 biomarker analysis from RATIONALE-306
    Raymond, E.
    Xu, J.
    Kato, K.
    Hubner, R.
    Shu, Y.
    Park, S. R.
    Kojima, T.
    Wyrwicz, L. S.
    Tougeron, D.
    Geboes, K.
    Van Cutsem, E.
    Pazo Cid, R. A.
    Zaanan, A.
    McLachlan, S-A.
    Wu, H.
    Shi, J.
    Li, L.
    Yan, S.
    Yoon, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S159 - S159
  • [9] Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy
    Xu, Liwei
    Qi, Yajun
    Jiang, Youhua
    Ji, Yongling
    Zhao, Qiang
    Wu, Jie
    Lu, Weishan
    Wang, Yinjie
    Chen, Qixun
    Wang, Changchun
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (06)
  • [10] ORIGINAL RESE ARCH The Safety and Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Retrospective Study
    Yin, Guo-Qiang
    Li, Zu-Lei
    Li, Dong
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2133 - 2141
12345